Wellbutrin XL, Major Depressive Disorder and Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Major Depressive Disorder
Interventions: DRUG: bupropion extended release (Wellbutrin XL)
Sponsor: Thomas Jefferson University
Collaborators: GlaxoSmithKline